This book provides an unparalleled description of current practices to enhance readers' knowledge and practice skills. This work was published by Saint Philip Street Press pursuant to a Creative Commons license permitting commercial use.
This book, written by leading experts in the field to enhance readers’ knowledge and practice skills, provides an unparalleled overview of the CAR-T cell technology and its application in clinical care, to enhance readers’ knowledge and ...
... blood from patients with high - risk myelodysplastic syndromes . Blood , 86 , 3660-3667 . De Witte , T ... leukemia and myelodysplasia following autologous transplantation for lymphoma : 182 MDS Complicating Stem Cell Transplantation.
In this book, world-renowned experts in the field express well-reasoned opinions on a range of issues and controversies relating to haploidentical transplantation with the aim of providing practicing hematologists with clinically relevant ...
... patients with myeloid metaplasia with myelofibrosis. Blood 2001; 98: 586–93. 115. Bader P, Niemeyer C, Willasch A et al. Children with myelodysplastic syndrome (MDS) and increasing mixed chimaerism after allogeneic stem cell transplantation ...
... Marrow Transplant. 2017;52:1107–12. 59. Shimoni A, Hardan I, Shem-Tov N, et al. Allogeneic hematopoietic stem-cell transplantation ... acute myeloid leukemia and myelodysplastic syndromes. Clin Oncol. 2017;35:1154–61. J 61. Kroger N ...
This book is open access under a CC BY 4.0 license.
... patients with myelofibrosis with myeloid metaplasia. Blood 2005; 105: 4115–4119. 96 Snyder DS, Palmer J, Stein AS, et al. Allogeneic hematopoietic cell transplantation following reduced intensity conditioning for treatment of ...
... patients with myelodysplastic syndrome. Blood 100(4):1201–1207 30. Armand P et al (2007) Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation. Blood 109(10):4586 ...
... hematopoietic stem‐cell transplantation with reduced‐intensity conditioning in intermediate‐ or high‐risk patients with myelofibrosis with myeloid metaplasia. Blood 2005; 105:4115–4119. Snyder DS, Palmer J, Stein AS, et al. Allogeneic ...